This compound was seen to exhibit dual p110α/mTOR inhibition (IC50 = 4 and 21nM, respectively), and displayed potent in vivo tumour growth inhibition in the PC3 prostate tumour xenograft model [81]. The gene discussed is MTOR; the disease is neoplasm.